29 November 2024
29 November 2024
Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.
Confirmation of the appointments is not yet assured and the Senate will vote to approve them early in 2025.
Norbert Bischofberger will step down from his position as president and CEO on 3 December 2024 but remain on the board of directors.
Meningitis C cases are down 99% since the NHS routine vaccination programme was introduced by UKHSA and NHS England in 1999.
This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024.
The funds will be utilised to progress the global clinical development of Allink's lead candidates, ALK201 and ALK202.
There are currently no available treatment options for any form of frontotemporal dementia that have been approved by the EMA or FDA.
The agreement grants Medvisis exclusive rights for the therapy in Switzerland and Liechtenstein.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
